3083467 Total Deaths

Total Page:16

File Type:pdf, Size:1020Kb

Load more

COVID-19 4/28 UPDATE COVID-19 4/28 Update Global Total cases – 3,083,467 Total deaths – 213,824 United States Positive tests – 1,002,498 (4% increase from prior day) % Positive tests – 18% Total # tests – 5,628,374 (4% increase from prior day) Total deaths – 57,266 (4% increase from prior day) Administration • The White House issued a 17-page strategy to expand U.S. testing for the coronavirus, after enduring criticism that the outbreak has grown to nearly 1 million Americans in part because the government was slow to develop and roll out a functional diagnostic. o The document the White House issued Monday describes a three-stage process to expand testing, with check marks in the first two stages indicating that they’re complete. The remaining stage calls for coordination with governors “to support testing plans and rapid response programs.” o Read action plan o Read blueprint • Dr. Deborah Birx and Health and Human Services Assistant Secretary Dr. Brett Giroir presented the eight-part plan at a press briefing on Monday. Giroir said the eight parts are grouped into three distinct phases. He said the US has accomplished all parts of the first two phases, and are now working to fulfill stage three by supporting reopening state economies. Here's what the blueprint suggests: o Stage 1: Launch § Build the foundation for diagnostic testing § Mobilize the private sector to develop tests § Issue Emergency Use Authorizations (EUAs) for tests § Galvanize commercial and research laboratories and professional associations to ramp up testing capacity § Facilitate state efforts to access and utilize all available testing capacity o Stage 2: Scale § Identify and expand public and private-sector testing infrastructure § Strengthen testing supply chain o Stage 3: Support opening up again § Coordinate with governors to support testing plans and rapid response programs § The White House said the federal government should act as the "supplier of last resort" for coronavirus tests as it works with states to ramp up a testing regime that health experts say is necessary before a national reopening. • The administration will also offer a blueprint laying out where it sees the boundaries between federal and state responsibilities. o A White House official said the goal was to help each state reach the ability to test at least 2% of its residents, with a particular focus on vulnerable populations and emergency workers. o The documents will also lay out what the administration has done so far to ramp up testing, including strengthening the US supply chain for supplies and testing kits. • White House economic adviser Kevin Hassett says the administration is weighing the idea of more aid to individuals, possibly adding to the first stimulus package’s $1,200 direct payment per qualified person. o House members also studying this, Hassett tells reporters at White House o “It’s very likely there’ll be a phase-four deal and we’re going to be speaking with the president throughout the week about what he thinks should be in there, and I know that Senator McConnell and Speaker Pelosi are working on that as well,” Hassett tells reporters o Earlier on CNN, Hassett said he sees the U.S. jobless rate at 16%-20% by june o He also says if some estimates are correct in predicting an economic rebound in 2nd half of 2020, it will be due to a strong bipartisan stimulus package • The US Food and Drug Administration authorized a coronavirus antibody test from Abbott Laboratories on Sunday, bringing the total number of FDA-authorized antibody tests to eight. o The Abbott test looks for a class of antibodies – called IgG antibodies – that are produced in the later stages of infection. Other tests can detect antibodies produced earlier. • President Trump is expected to sign a five-page executive order under the Defense Production Act today that compels meat processing plants to remain open, CNN has learned. o Trump is expected to sign the order after some companies, like Tyson, were considering only keeping 20% of their facilities open. The vast majority of processing plans could have shut down, which would have reduced processing capacity in the country by as much as 80%, an official familiar says. o By signing the order, Trump will declare these plants as a part of critical infrastructure in the US. o The administration is also working with the Labor Department on issuing guidance about which employees should remain home. This is to protect facilities that are required to stay open from liability issues. o Trump previewed the order earlier today during an Oval Office spray with Florida Gov. Ron DeSantis, saying that he expects to sign an executive order later in the day related to the food supply chain. • President Trump, Vice President Mike Pence, and members of the coronavirus task force briefed the nation's governors Monday afternoon on a new testing blueprint. o According to audio of the call obtained by CNN, Trump said the US has now completed 5.4 million tests and the number of tests being performed each day has "began to skyrocket," citing more than 200,000 tests performed last Wednesday. He praised governors who have implemented testing strategies and contracted with the public and private sector to get what they need. • Admiral Brett Giroir, director of US coronavirus testing, said the federal government will continue to help states procure supplies for testing, despite new guidelines that describe it as a “supplier of last resort” in obtaining tests. o “It’s very important that I think we don’t interrupt our commercial channels, because they’re very efficient and this is what they do, but we do have to prioritize them,” Giroir told reporters at the White House on Monday. o “Some of the larger companies, the testing companies, we need to make sure that the states that have a certain machine or a certain test are adequately supplied until we get 10 times the amount that we need," he added. o Giroir described supplies like swabs as a “small, fragile ecosystem right now.” o “For the next couple of months, we’re going to procure them at the federal level to make sure they’re distributed to the states,” he said, “but towards the middle or the end of the summer that supply chain will be very robust.” o Starting as early as late next week, Giroir said, “for say, swabs and media, we know what the plan is. • President Trump says he takes no responsibility for a spike in people using disinfectants improperly after he suggested ingesting disinfectant as a cure for coronavirus last week. o When asked about the increase, Trump said, "I can't imagine why." o He answered, “No, I don’t" when asked if he takes any responsibility for the numbers. • President Trump described governors as “as thrilled as they can be” over the administration's response to the coronavirus, hours after a meeting with state leaders on Monday. o “We had a fantastic call with the governors today,” the President said during a Rose Garden briefing. “And I would say that today are as thrilled as they can be considering that to the fact is that there has been so much unnecessary death in this country.” o “It could have been stopped,” Trump added, “and it could've been stopped short, but somebody a long time ago it seems decided not to do it that way, and the whole world is suffering because of it, 184 countries at least.” • President Trump says he is confident there is enough coronavirus testing to reopen the country. o U.S. has more than doubled testing capacity and will double again, Trump says at White House briefing o Trump says he has directed Medicare to make “‘it easier” for seniors to get testing • President Trump met with executives from companies including Walgreens, Walmart, Rite-Aid, CVS, Quest Diagnostics, LabCorp and Thermo Fisher o " President Donald Trump and retailers are expected to announce wider availability of coronavirus tests as his administration seeks to address concerns from states and business leaders that U.S. testing must be more robust for Americans to feel comfortable returning to work. • In pushing to start reopening the country, the White House has fielded broad concerns from business leaders and states that the U.S. doesn’t have sufficient testing to relent on social-distancing practices that have crippled the economy. o At Monday’s event, it isn’t clear whether the president will address shortages of materials needed to expand testing, including swabs to collect samples and chemical media to transport them to labs. • President Trump defended Health and Human Services Secretary Alex Azar, who downplayed the impact of coronavirus in the early stages of the pandemic. o “I think it’s a very unfair question because you have many great professionals, some of them you have great respect for, and you have many people in the other party… that have said the same thing and with even more confidence,” Trump said when asked about Azar's role. “So a lot of people didn’t get that right." • The U.S. Small Business Administration didn’t resume accepting applications for disaster loans on Monday because the additional money authorized by Congress could be exhausted by previous applicants, agency officials confirmed. o “The SbA is unable to accept new applications at this time for COVID-19 Economic Injury Disaster Loan- related assistance…based upon available appropriations funding,” said Matt Coleman, a spokesman for SbA’s Region II, which includes New York State. o “Applicants who have already submitted their applications will continue to be processed on a first come, first serve basis,” he said on Monday.
Recommended publications
  • Biden: Nominations by Both Biden and 3

    Biden: Nominations by Both Biden and 3

    Will the ETHNIC FACTOR in Biden's KEY cabinet members preclude again (as it did with Trump’s KEY cabinet members) bringing home some 70,000 U.S. troops whose deployment for Israel’s security and prosperity in the Middle East cost some $8 trillion and millions of people killed or displaced in that region? Biden's top Jewish picks met well a minyan and a half These disproportionate ethno- Trump: U.S. troops will remain in the Middle East for Israel, political appointments or 1. White House Chief of Staff Ron Klain The Washington Post, 11/28/2018, https://www.jpost.com/Middle-East/Trump-US-troops-will-remain-in-the-Middle-East-for-Israel-572997 2. Secretary of State Antony Blinken Biden: nominations by both Biden and 3. Secretary of the Treasury Janet Yellen “They will Trump in addition to dozens of Iraq Was Invaded 'to Protect Israel' , https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1475-4967.2006.00260.x 4. US Ambassador to Israel Tom Nides tell me what elected Jewish Members of Remember: The "ardent faith" of the war in Iraq was conceived and 5. Secretary of Homeland Security Alejandro Mayorkas I need to Congress can only give a disseminated by a small group of 25 or 30 neoconservatives, almost all of 6. Member of Council of Economic Advisers Jared Bernstein know, not glimpse of the Power of Israel them Jewish, almost all of them intellectuals (a partial list: Richard Perle, Paul 7. Special Presidential Envoy for Climate John Kerry/Cohen what I want in the United States and the Wolfowitz, Douglas Feith, William Kristol, Eliot Abrams, Charles 8.
  • Ways and Means Committee's Request for the Former President's

    Ways and Means Committee's Request for the Former President's

    (Slip Opinion) Ways and Means Committee’s Request for the Former President’s Tax Returns and Related Tax Information Pursuant to 26 U.S.C. § 6103(f )(1) Section 6103(f )(1) of title 26, U.S. Code, vests the congressional tax committees with a broad right to receive tax information from the Department of the Treasury. It embod- ies a long-standing judgment of the political branches that the tax committees are uniquely suited to receive such information. The committees, however, cannot compel the Executive Branch to disclose such information without satisfying the constitutional requirement that the information could serve a legitimate legislative purpose. In assessing whether requested information could serve a legitimate legislative purpose, the Executive Branch must give due weight to Congress’s status as a co-equal branch of government. Like courts, therefore, Executive Branch officials must apply a pre- sumption that Legislative Branch officials act in good faith and in furtherance of legit- imate objectives. When one of the congressional tax committees requests tax information pursuant to section 6103(f )(1), and has invoked facially valid reasons for its request, the Executive Branch should conclude that the request lacks a legitimate legislative purpose only in exceptional circumstances. The Chairman of the House Ways and Means Committee has invoked sufficient reasons for requesting the former President’s tax information. Under section 6103(f )(1), Treasury must furnish the information to the Committee. July 30, 2021 MEMORANDUM OPINION FOR THE ACTING GENERAL COUNSEL DEPARTMENT OF THE TREASURY The Internal Revenue Code requires the Department of the Treasury (“Treasury”) and the Internal Revenue Service (“IRS”) to keep tax returns and related information confidential, 26 U.S.C.
  • Speaker Bios

    Speaker Bios

    SPEAKER BIOGRAPHIES The Honorable Deborah Birx, MD Deborah L. Birx, MD is Ambassador-at-Large and Coordinator of the United States government activities to combat HIV/AIDS globally. Ambassador Birx is a world-renowned medical expert and leader in the field of HIV/AIDS whose three decade-long career has focused on HIV/AIDS immunology, vaccine research, and global health. As the U.S. Global AIDS Coordinator, Ambassador Birx oversees the implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to combat a single disease in history, as well as all U.S. government engagement with the Global Fund to Fight AIDS, Tuberculosis, and Malaria. In 1985, Ambassador Birx began her career with the Department of Defense (DoD) as a military trained clinician in immunology, focusing on HIV/AIDS vaccine research. From 1985-1989 she served as an Assistant Chief of the Hospital Immunology Service at Walter Reed Army Medical Center. Through her professionalism and leadership in the field, she progressed to serve as the Director of the U.S. Military HIV Research Program (USMHRP) at the Walter Reed Army Institute of Research from 1996-2005. Ambassador Birx helped lead one of the most influential HIV vaccine trials in history (known as RV 144, or the Thai trial), which provided the first supporting evidence of any vaccine’s potential effectiveness in preventing HIV infection. During this time, she also rose to the rank of Colonel, bringing together the Navy, Army, and Air Force in a new model of cooperation – increasing the efficiency and effectiveness of the U.S.
  • Administration of Donald J. Trump, 2020 Remarks on Coronavirus

    Administration of Donald J. Trump, 2020 Remarks on Coronavirus

    Administration of Donald J. Trump, 2020 Remarks on Coronavirus Vaccine Development November 13, 2020 The President. Thank you very much. Thank you. It's beautiful out here this time of year. In the past 9 months, my administration has initiated the single greatest mobilization in U.S. history, pioneering, developing, and manufacturing therapies and vaccines in record time. Numbers like nobody has seen before. No medical breakthrough of this scope and magnitude has ever been achieved this rapidly, this quickly. And we're very proud of it, and I had tremendous help from the military—generals, admirals—and many of the great people at the White House. Operation Warp Speed is unequaled and unrivaled anywhere in the world, and leaders of other countries have called me to congratulate us on what we've been able to do, and we've helped many countries with their ventilators and all of the problems they were having. And I'd like to congratulate everyone involved in this effort. It's been an incredible effort. As a result of Operation Warp Speed, Pfizer announced on Monday that its "China virus" vaccine is more than 90-percent effective. This far exceeds any and all expectations. Nobody thought they'd get to that level. And we have others coming which we think will be at equal level—maybe more, if that's possible. In July, my administration reached an agreement with Pfizer to provide $1.95 billion to support the mass manufacturing and distribution of 100 million doses, with the option to purchase a total of 600 million doses shortly thereafter.
  • Notes from White House Briefing Call 6.10.2020

    Notes from White House Briefing Call 6.10.2020

    State, Local, and Tribal Leaders – Thank you to the State, local, and Tribal leaders who joined Vice President Mike Pence and Senior Administration Officials for the White House COVID-19 National Briefing Call on Wednesday, June 10. Attendees heard comprehensive updates and insights on continuing support for State, local, and Tribal response, recovery, and reopening efforts from Vice President Pence, Ambassador Deborah Birx (White House Coronavirus Task Force Coordinator), Secretary Ben Carson (U.S. Department of Housing and Urban Development), Secretary Eugene Scalia (U.S. Department of Labor), and Secretary Betsy DeVos (U.S. Department of Education). The Vice President also expressed his appreciation for the great work and sacrifice from America’s State, local, and Tribal leaders and also asked call attendees to share his, President Trump’s, and the entire Administration’s appreciation for our Nation’s first responders and healthcare workers. Find several examples from State and local leaders here, here, here, here, and here. Below, please find pertinent updates and a recap from the call. Recent Announcements President Trump Hosts Law Enforcement Roundtable: On Monday, President Trump held a roundtable discussion with law enforcement officials at the White House, where officers discussed responsible ideas for reform and ways for police officers to act as better friends for their communities. “There’s a reason for our less crime – it’s because we have great law enforcement. I’m very proud of them. There won’t be defunding, there won’t be dismantling of our police, and there are not going to be any disbanding of our police,” the President stated.
  • COVID-19: a Weekly Health Care Update from Washington April 13-17, 2020

    COVID-19: a Weekly Health Care Update from Washington April 13-17, 2020

    COVID-19: A Weekly Health Care Update from Washington April 13-17, 2020 IN BRIEF What Happened This Week: Negotiators failed to reach consensus on a proposal to provide additional support for small businesses this week (hospital funding was one of the major sticking points, although negotiations are progressing). Meanwhile, at the White House, President Trump and members of the Coronavirus Task Force unveiled the details of a new phased approach to “reopen” the nation’s the economy yesterday and instructed state governors to take the lead. What to Expect in the Weeks and Months Ahead: Expect lawmakers to continue negotiating a path forward for additional small business support; expect lawmakers to continue working remotely on additional measures tied to the pandemic; and expect the Trump Administration to continue providing clarity and guidance on the distribution of funds and implementation of other major provisions in the first three COVID-19 bills. DEEP DIVE President Trump Unveils “Guidelines for Opening Up America Again”; Instructs State Governors to Take the Lead on a Phased Reopening of the Economy President Trump and members of the White House Coronavirus Task Force unveiled the details of a new phased “reopening” of the nation’s economy using a “deliberate, data-driven approach.” The Administration leaves much of the decision-making to the states but instructs them to open up gradually after benchmarks on new cases, testing, and hospital resources are met. As far as timing goes, Coronavirus Task Force Response Coordinator Dr. Deborah Birx said there is no set schedule for any of the guideline’s three phases.
  • Kentucky Hospital Research & Education Foundation Emergency

    Kentucky Hospital Research & Education Foundation Emergency

    Kentucky Hospital Research & Education Foundation Emergency Preparedness Update for December 11, 2020 KY COVID Positivity Rate Drops Below 9% (Press release) Today, Gov. Andy Beshear announced the state’s positivity rate has decreased for the eighth straight day, now dropping under 9%; reaching 8.86%. As of 4 PM, new cases for today totaled 3,691, with 22 new deaths. 1,717 patients are in the hospital, with 432 in the ICU and 253 on vents. Full press release: https://kentucky.gov/Pages/Activity-stream.aspx?n=GovernorBeshear&prId=506 KY COVID-19 Daily Summary: https://chfs.ky.gov/agencies/dph/covid19/COVID19DailyReport.pdf ---------- U.S. FDA set to authorize Pfizer COVID-19 vaccine (Reuters) - The U.S. Food and Drug Administration said on Friday it was working rapidly to issue an emergency use authorization (EUA) for Pfizer Inc’s COVID-19 vaccine, with the green light coming possibly as soon as Friday evening, according to the New York Times. The newspaper reported on Friday that the FDA is likely to issue the EUA by Friday evening, citing people familiar with the agency’s planning. It had reported on Thursday night that the FDA would announce the news on Saturday. Swift clearance of the vaccine was widely expected after a panel of expert advisers to the FDA on Thursday endorsed its emergency use to help stem a pandemic that has killed more than 285,000 people in the United States. Full story: https://www.reuters.com/article/health-coronavirus-fda-pfizer/us-fda-set-to-authorize-pfizer-covid-19-vaccine-idUSKBN28L1IG ---------- CDC Projects
  • Presentation Center

    Presentation Center

    Trump Administration Tracker: Department of the Treasury September 28, 2017 Department of the Treasury Organizational chart *Boxes corresponding to divisions, rather than Inspector General positions, refer to the head of said division Office of the Secretary of the Treasury Treasury Inspector General Office of the Chief of Staff for Tax Administration Deputy Secretary of the Treasury Special Inspector General, Not yet nominated Nominated Confirmed Troubled Asset Relief Program Not yet appointed Appointed Withdrew Office of International Office of Terrorism and Office of the Treasurer Office of Domestic Finance Affairs Financial Intelligence Office of Office of Office of Office of Financial Financial International Intelligence Institutions Markets Finance and Analysis Office of Office of Terrorist Office of Office of Fiscal Financial Financing and Intelligence Financial Crimes Service Stability and Analysis Office of Office of General Office of Office of Office of Tax Chief Risk Economic Legislative Counsel Management Public Affairs Policy Officer Policy Affairs Sources: Department of the Treasury; National Journal Research 1 Department of the Treasury Nomination tracker Position Obama Administration Trump Administration Status Secretary of the Treasury Jack Lew Steven Mnuchin Nominated (11/29/16) (Confirmed 2/28/13) Confirmed (2/13/17) Deputy Secretary of the Treasury Sarah Raskin James Donovan Nominated (3/15/17) (Confirmed 3/19/14) (Withdrew 5/19/17) Nominated (6/12/17) Brian Brooks Office of the Treasurer Rosa Rios N/A Nominated (N/A)
  • Stuyvesant Student Opportunity Bulletin #37L June 11, 2021

    Stuyvesant Student Opportunity Bulletin #37L June 11, 2021

    Stuyvesant Student Opportunity Bulletin #37L June 11, 2021 Please note that in this “Long” version of the Student Opportunity Bulletin, all opportunities in each category are included. For the list of only the New and Deadline Approaching opportunities in each category, you may click & open the “Short” version of the Student Opportunity document you received. CATEGORY TABLE OF CONTENTS: (Download this entire PDF document in order to use the following links to jump to your area(s) of interest) 1. EVENTS OF INTEREST TO STUDENTS 2. ACADEMIC PROGRAMS 3. BUSINESS & JOBS 4. COMMUNITY SERVICE 5. LEADERSHIP, GOVERNMENT, LAW, ADVOCACY, INTERNATIONAL 1 6. MUSEUMS & ART 7. PARKS, ZOOS, & NATURE 8. STEM OPPORTUNITIES a. ENGINEERING / MATH / COMPUTER SCIENCE b. MEDICAL / LIFE SCIENCES 9. THEATER, WRITING, MUSIC, PERFORMING ARTS, VIDEO 10. CONTESTS & COMPETITIONS 11. OPPORTUNITY LISTS AND RESOURCES 12. SCHOLARSHIPS This edition includes some new events & opportunities in most of the sections below– many have deadlines coming up in the next week or two- so please explore them ASAP. For example: --In the ACADEMICS section, there is a free summer STEP/STEM program offered by Vaughn College of Aeronautics – it is targeted for low-income 2 students or those from under-represented groups, but all may apply – the deadline to do so is Monday, June 14! And today is the application deadline for free summer classes with the TGR Foundation and The BMCC College Now Program. --In the BUSINESS/JOBS section, there are deadlines this week for several virtual Internship Programs, a personal financial literacy program for high school students, a virtual Career Day, and a free summer Externship Program covering development of business knowledge & skills offered by AT&T.
  • COVID-19: a Weekly Health Care Update from Washington May 4-8, 2020 in BRIEF DEEP DIVE

    COVID-19: a Weekly Health Care Update from Washington May 4-8, 2020 in BRIEF DEEP DIVE

    COVID-19: A Weekly Health Care Update from Washington May 4-8, 2020 IN BRIEF What Happened This Week: The Senate returned to Washington this week and conducted a handful of COVID-related hearings – all with modified layouts in an effort to adhere to social distancing guidelines. The Trump Administration posted several resources online for providers and facilities seeking clarification on the distribution of Provider Relief Funds. The Department also announced the distribution of over $500 million in funding under the recently enacted Paycheck Protection Program and Health Care Enhancement Act to expand COVID-19 testing nationwide. Members of the House of Representatives still have not returned, but the Democratic majority continues to put the finishing touches on another round of legislation to respond to the pandemic. What to Expect Next Week: Expect the Senate to reconvene in Washington next week. The House schedule is still fluid, although it’s possible that Members could be called on to return to Washington as well. It’s also possible that House Democratic Leadership will reveal the details of their next COVID-19 legislative response proposal (CARES Act “2.0”). DEEP DIVE Senate Returns to Washington After Five Weeks of Working Remotely Senators returned to Washington on Monday, May 4 after working remotely for weeks due to the coronavirus. In an effort to pick up with business as usual, the chamber conducted a handful of hearings this week, including one held by members of the Senate HELP Committee to examine new coronavirus tests. Witnesses included NIH Director Dr. Francis Collins and BARDA Acting Director Dr.
  • Myth of the Paycheck Protection Program

    Myth of the Paycheck Protection Program

    The “Small Business” Myth of the Paycheck Protection Program Thomas W. Joo†* and Alex Wheeler** Congress responded to the pandemic-induced recession with the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act. A highly publicized feature of the Act was the Paycheck Protection Program (“PPP”). Congress presented the PPP’s forgivable loans as a lifeline for small businesses reeling from loss of revenue. When initial funding for the program was quickly exhausted, the media, politicians, and the public excoriated large corporations, such as Shake Shack and AutoNation, for having taken millions in PPP loans. This paper argues that despite the universal condemnation, large corporations like these acted consistently with the intent of the PPP. Instead, the real blame falls on Congress for carelessly designing a program without a coherent policy objective. Although politicians characterized the PPP as a rescue program for small business, it was designed to assist a wide range of firms, with no preference for very small, disadvantaged, or economically troubled firms. The PPP was not limited to businesses that lacked other access to capital, and explicitly included hotel and restaurant chains and large franchise networks. Despite its generous terms and wide applicability, the PPP also contained arbitrary and confusing restrictions on how loan † Copyright © 2020 Thomas W. Joo and Alex Wheeler. * Martin Luther King Jr. Professor of Law, University of California, Davis, School of Law. ** J.D. candidate, University of California, Davis, School of Law, Class of 2022. 21 22 UC Davis Law Review Online [Vol. 54:21 proceeds could be used. The misinformed condemnation of large companies obscured the fact that Congress had designed a flawed program with limited ability to help small businesses.
  • The Opioid Epidemic and Emerging Public Health Policy Priorities

    The Opioid Epidemic and Emerging Public Health Policy Priorities

    OFFICE OF THE ASSISTANT SECRETARY FOR HEALTH THE OPIOID EPIDEMIC AND EMERGING PUBLIC HEALTH POLICY PRIORITIES PRESENTED TO THE AMA NATIONAL ADVOCACY CONFERENCE February 13, 2019 ADMIRAL BRETT P. GIROIR, M.D. Assistant Secretary for Health and Senior Advisor for Opioid Policy THE STATE OF OPIOID MISUSE IN AMERICA (2017) 11.4 million 2.1 million 53.1% people misused opioids people had an opioid obtained the last in the past year use disorder pain reliever they - 11.1 million misused pain relievers - 1.7 million people with a prescription misused from a pain reliever use disorder - 886,000 used heroin friend or relative - 652,000 people with a heroin use - 562,000 both misused pain disorder relievers and heroin - 252,000 had both pain reliever and 36% heroin use disorders from a prescription from a healthcare Main reasons for opioid misuse: Pain 62.6% provider OFFICE OF THE NSDUH, 2017 Data; published Sept. 2018 ASSISTANT SECRETARY FOR HEALTH 2 U.S. DRUG OVERDOSE DEATHS THE MOST CRITICAL PUBLIC HEALTH CHALLENGE OF OUR TIME 80,000 70,000 70,237 All Drug 60,000 Overdoses 50,000 47,600 40,000 Opioid 30,000 Overdoses 20,000 10,000 0 OFFICE OF THE SOURCE: NCHS, National Vital Statics System, Mortality ASSISTANT SECRETARY FOR HEALTH 3 OVERDOSE MORTALITY BY CLASS OF DRUG ADAPTED FROM CDC STATISTICS, JANUARY 2019 NAT & SEMI – SYNTHETIC PSYCHO- HEROIN METHADONE COCAINE SYNTHETIC OPIOIDS STIMULANTS JUNE 2017 * 16,622 15,546 3,357 26,057 13,367 9,446 JUNE 2018 * 15,283 13,929 3,283 31,551 15,095 11,741 Change -8.06% -10.04% -2.20% 21.08% 12.93% 24.30% https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm >70% of Cocaine Deaths also have Opioids Detected OFFICE OF THE • Number of predicted deaths for the 12 months ending in June of the indicated year ASSISTANT SECRETARY FOR HEALTH 4 4 SHOCKING LEVELS OF ILLICIT DRUG SMUGGLING Feds make largest fentanyl bust in U.S.